Amid increasing investor interest in the telehealth sector, a recent Department of Justice (“DOJ”) prosecution involving Done Global underscores evolving enforcement risks for telehealth platforms, management services...more
1/15/2026
/ Controlled Substances ,
Controlled Substances Act ,
Corporate Practice of Medicine ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Digital Health ,
Enforcement Actions ,
Health Care Providers ,
Healthcare Fraud ,
Investors ,
Prescription Drugs ,
Regulatory Oversight ,
Telehealth ,
Telemedicine